2007 National Medical Circulation Of Hundred Key Enterprises
2007 National Medical circulation hundred enterprises “list released, China Pharmaceutical Group Corporation, Shanghai Pharmaceutical shares, Kyushu through three companies to become the biggest winner, total sales of 77.337 billion yuan, accounting for the total pharmaceutical sales of the commercial market 19.21% over 2006 increased 0.26 percentage points.
“2008 Pharmaceutical market Presents six characteristics: First, Medical Reform Heavy volume driven market, generic drugs, generic drugs to expand space for development; second, further speeding up the rural market expansion and distribution system is the most important; 3 is the industry more competitive, competition continues to expand around the channel; Fourth, enterprises should continue to develop and profitability, lower cost efficiency tasks are still outstanding; Fifth policies to boost the Chinese industrial structure adjustment, “integration, upgrade, competing” features highlights; Sixth, reform and development are still issues facing the future, adapt to the new health care reform a difficult task. ”
Organized by the China Business Association of Traditional Chinese Medicine assessed the “flow of the 2007 National Medical hundred enterprises” list recently announced. According to statistical data analysis, this year’s pharmaceutical distribution business hundred finalists from the 2006 baseline of 580 million yuan to upgrade to 6.3 million companies see significantly improved the overall size. The total emission of the national sales volume more than 10 billion yuan Chinese enterprises have three, followed by China Pharmaceutical Group Corporation, Shanghai Pharmaceutical Co., Ltd., Kyushu Group Limited, the three largest pharmaceutical wholesale business had sales in 77.337 billion yuan, accounting for the total pharmaceutical market business 19.21%, compared to 2006 increased 0.26 percentage points.
Market concentration significantly enhance the economies of scale on
Of “medicine circulation hundred enterprises” list can be found in the domestic large companies, large corporations retaining its position as the forefront of medicine circulation hundred enterprises. Sinopharm Holdings Limited, Shanghai Pharmaceutical Co., Ltd., Kyushu Tong Group Co., Ltd., Nanjing Medical Co., Ltd., Guangzhou Pharmaceutical Co., Ltd., Anhui Huayuan Pharmaceutical Co., Ltd., Chongqing Pharmaceutical Co., Ltd., Beijing Pharmaceutical Co., Ltd., East Medical Co., Ltd., Zhejiang Intel Pharmaceutical Co., Ltd., Tianjin Pacific (Group) Company Limited, Harbin Pharmaceutical Group Co., Ltd. Chinese medicine, lerentang Pharmaceutical Co., Ltd., Yunnan Province, pharmaceutical companies, new drugs in Xinjiang Folk medicine Industry Co., Ltd., a large pharmaceutical distribution companies, large corporations the status of outstanding medical market. 20 in strong
2007 Pharmaceutical Industry Sales volume growth, higher than the industry growth rate. Among them, Sinopharm Holdings Limited to 48.23 percent increase; Nanjing Pharmaceutical Company Limited to 44.57 percent; East China Pharmaceutical Co., Ltd. to 37.94 percent; lerentang Pharmaceutical Co., Ltd. to 29.57 percent; Yunnan pharmaceutical company to 29.51 percent; Beijing Traditional Chinese Medicine Limited to 27.43%; Sinopharm Pharmaceutical Co., Ltd. to 24.72%; Hubei Kyushu Group Limited to 23.68%; Harbin Pharmaceutical Group Co., Ltd. to 21.37% of Traditional Chinese Medicine; Chongqing Pharmaceutical Co., Ltd. to 19.69%.
Profitability increased profitability have recovered 2007, the national pharmaceutical business gross margin was 7.89%, the cost rate of 6.48%, 1.21% margin. Which new drugs national pharmaceutical companies in Xinjiang, Zhejiang Huadong Medicine Co., Ltd., Harbin Pharmaceutical Group Co., Ltd. medicine, Sinopharm Pharmaceutical Co., Ltd., Guangzhou Pharmaceutical Company Limited, Tianjin Pacific (Group) Co., Ltd., Shanghai Pharmaceutical Co. shares company, Zhejiang Intel Pharmaceutical Co., Ltd., Wuhan Medical Corporation, Yunnan Province, sales of pharmaceutical companies profit margins are more than 1%, much higher than the industry average; Sinopharm Group Co., Ltd., Shanghai State-controlled companies, Kyushu Pass Group Limited, Sinopharm Group Pharmaceutical Co., Ltd., Shanghai Pharmaceutical Co., Ltd., Nanjing Medical Co., Ltd., Guangzhou Pharmaceutical Company Limited, Shenzhen consistent Pharmaceutical Co., Ltd., state-controlled companies such as Guangzhou, the annual profit over 100 million yuan . The top 20 pharmaceutical distribution companies accounted for the profits of pharmaceutical companies combined 69.17 percent of commercial profits, market concentration and economic concentration significantly increased.
Scale enterprises dominate the leading position of regional stability
I am a professional writer from China Hardware Suppliers, which contains a great deal of information about birch plywood furniture , ash wood veneer, welcome to visit!
Processing your request, Please wait....
